Mealey's (January 24, 2020, 1:42 PM EST) -- LOS ANGELES — In a Jan. 21 memorandum, a patent owner and patent licensee assert that a California federal judge should double a jury’s recent $752 million award for infringement of a cancer immunotherapy patent; the same day, the defendant in the case sought judgment as a matter of law (JMOL) that the patent in suit is invalid (Juno Therapeutics Inc., et al. v. Kite Pharma Inc., No. 17-7639, C.D. Calif.)....